← Open Payments lookup

KRISTIN HANCOCK: Open Payments

NPI 1740809706 · SPRING BRANCH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$764 in 33 payments from 13 companies in 2025. Trend: 2023 $615 · 2024 $819 · 2025 $764

Food & beverage: $764
CompanyPaymentsAmount
ABBVIE INC.5$208
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$109
Takeda Pharmaceuticals U.S.A., Inc.4$95
Aimmune Therapeutics, Inc.3$59
Madrigal Pharmaceuticals3$55
Ipsen Biopharmaceuticals, Inc3$50
GENZYME CORPORATION2$47
Celltrion USA Inc.2$41
Ardelyx, Inc.1$24
VIVUS LLC1$21

Products named: XIFAXAN, VOWST, REZDIFFRA, IQIRVO, ENTYVIO, DUPIXENT, EOHILIA, VEGZELMA.

Industry payments across TX — which companies pay providers there.